• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部癌症特征相关的分子和细胞过程。

Molecular and cellular processes underlying the hallmarks of head and neck cancer.

机构信息

University Department of Otolaryngology-Head and Neck Surgery, Manchester Royal Infirmary, Oxford Road, Manchester, M13 9WL, UK.

出版信息

Eur Arch Otorhinolaryngol. 2013 Sep;270(10):2585-93. doi: 10.1007/s00405-012-2323-x. Epub 2012 Dec 23.

DOI:10.1007/s00405-012-2323-x
PMID:23263268
Abstract

The hallmarks of cancer were updated by Hanahan and Weinberg in 2011. Here we discuss the updated hallmarks in relation to what is known of the molecular and cellular processes underlying the development of head and neck squamous cell carcinoma (HNSCC). Several mechanisms are described, and recent surveys of HNSCC suggest a limited number of mutations, from which more mechanisms may emerge. There are also epigenetic changes to the control of normal processes. More than one mechanism underlies each hallmark. Processes essential to the development of HNSCC need not be essential to the proliferation of the fully developed tumour. Attention is paid to the emerging hallmarks, deregulation of cellular energy metabolism and evasion of immune destruction, and enabling characteristics, genome instability and mutation and tumour-promoting inflammation. HNSCC may adapt to hypoxia, suppress HLA expression, and express Toll-like receptors to facilitate inflammation, which support the proliferation of the tumour.

摘要

2011 年,Hanahan 和 Weinberg 更新了癌症的标志性特征。在这里,我们讨论了这些更新的标志性特征,以及它们与已知的头颈部鳞状细胞癌(HNSCC)发生的分子和细胞过程的关系。我们描述了几种机制,并且最近对头颈部鳞状细胞癌的调查表明,突变的数量有限,可能会出现更多的机制。正常过程的控制也存在表观遗传变化。每个标志性特征都有不止一种机制。对头颈部鳞状细胞癌发展至关重要的过程,不一定对头颈部鳞状细胞癌完全发展的肿瘤的增殖至关重要。我们关注新兴的标志性特征,细胞能量代谢的失调和逃避免疫破坏,以及使能特征,基因组不稳定性和突变以及促进肿瘤炎症。HNSCC 可能会适应缺氧,抑制 HLA 表达,并表达 Toll 样受体以促进炎症,从而支持肿瘤的增殖。

相似文献

1
Molecular and cellular processes underlying the hallmarks of head and neck cancer.头颈部癌症特征相关的分子和细胞过程。
Eur Arch Otorhinolaryngol. 2013 Sep;270(10):2585-93. doi: 10.1007/s00405-012-2323-x. Epub 2012 Dec 23.
2
Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.MGMT、MLH1 和 RASSF1A 肿瘤抑制基因启动子甲基化与头颈部鳞状细胞癌:药物基因组去甲基化可降低头颈部鳞状细胞癌细胞的增殖。
Oncol Rep. 2012 Apr;27(4):1135-41. doi: 10.3892/or.2012.1624. Epub 2012 Jan 9.
3
Toll-like receptor modulation in head and neck cancer.
Crit Rev Immunol. 2008;28(3):201-13. doi: 10.1615/critrevimmunol.v28.i3.20.
4
γ-Secretase inhibitor reduces immunosuppressive cells and enhances tumour immunity in head and neck squamous cell carcinoma.γ-分泌酶抑制剂减少头颈部鳞状细胞癌中的免疫抑制细胞并增强肿瘤免疫。
Int J Cancer. 2018 Mar 1;142(5):999-1009. doi: 10.1002/ijc.31115. Epub 2017 Nov 2.
5
Blockade of adenosine A2A receptor enhances CD8 T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma.腺苷A2A受体阻断增强头颈部鳞状细胞癌中CD8 T细胞反应并减少调节性T细胞
Mol Cancer. 2017 Jun 7;16(1):99. doi: 10.1186/s12943-017-0665-0.
6
Dysregulation of junctional adhesion molecule-A via p63/GATA-3 in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中通过p63/GATA-3导致连接粘附分子A失调
Oncotarget. 2016 Jun 7;7(23):33887-900. doi: 10.18632/oncotarget.8432.
7
The role of HOX genes in head and neck squamous cell carcinoma.HOX基因在头颈部鳞状细胞癌中的作用。
J Oral Pathol Med. 2016 Apr;45(4):239-47. doi: 10.1111/jop.12388. Epub 2015 Dec 14.
8
Tumor suppressor activity of CCAAT/enhancer binding protein alpha is epigenetically down-regulated in head and neck squamous cell carcinoma.CCAAT/增强子结合蛋白α的肿瘤抑制活性在头颈部鳞状细胞癌中发生表观遗传下调。
Cancer Res. 2007 May 15;67(10):4657-64. doi: 10.1158/0008-5472.CAN-06-4793.
9
Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.肿瘤抑制性miR-1和miR-206对头颈部鳞状细胞癌的双受体(EGFR和c-MET)抑制作用
J Hum Genet. 2017 Jan;62(1):113-121. doi: 10.1038/jhg.2016.47. Epub 2016 May 12.
10
Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).抑瘤 microRNA-375 调控头颈部鳞状细胞癌(HNSCC)中的癌基因 AEG-1/MTDH。
J Hum Genet. 2011 Aug;56(8):595-601. doi: 10.1038/jhg.2011.66. Epub 2011 Jul 14.

引用本文的文献

1
Small extravesicular microRNA in head and neck squamous cell carcinoma and its potential as a liquid biopsy for early detection.头颈部鳞状细胞癌中小囊外 microRNA 及其作为液体活检用于早期检测的潜力。
Head Neck. 2023 Jan;45(1):212-224. doi: 10.1002/hed.27231. Epub 2022 Oct 22.
2
An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer.一种肿瘤浸润淋巴细胞的影像学生物标志物,用于风险分层 HPV 相关口咽癌患者。
J Natl Cancer Inst. 2022 Apr 11;114(4):609-617. doi: 10.1093/jnci/djab215.
3
Association Between Interleukin-6 and Head and Neck Squamous Cell Carcinoma: A Systematic Review.

本文引用的文献

1
Galectins as cancer biomarkers.半乳糖凝集素作为癌症生物标志物。
Cancers (Basel). 2010 Apr 20;2(2):592-610. doi: 10.3390/cancers2020592.
2
Prognostic value of vascular endothelial growth factor in patients with head and neck cancer: A meta-analysis.血管内皮生长因子对头颈癌患者预后的价值:一项荟萃分析。
Head Neck. 2013 Oct;35(10):1507-14. doi: 10.1002/hed.23156. Epub 2012 Sep 18.
3
Delineating metabolic signatures of head and neck squamous cell carcinoma: phospholipase A2, a potential therapeutic target.描绘头颈部鳞状细胞癌的代谢特征:磷脂酶 A2,一个潜在的治疗靶点。
白细胞介素-6与头颈部鳞状细胞癌的关联:一项系统综述。
Clin Exp Otorhinolaryngol. 2021 Feb;14(1):50-60. doi: 10.21053/ceo.2019.00906. Epub 2021 Feb 1.
4
Primary Extracellular Matrix Enables Long-Term Cultivation of Human Tumor Oral Mucosa Models.原发性细胞外基质可实现人肿瘤口腔黏膜模型的长期培养。
Front Bioeng Biotechnol. 2020 Dec 4;8:579896. doi: 10.3389/fbioe.2020.579896. eCollection 2020.
5
Transcription Factors in Cancer Development and Therapy.癌症发展与治疗中的转录因子
Cancers (Basel). 2020 Aug 15;12(8):2296. doi: 10.3390/cancers12082296.
6
Targeting Transcription Factors for Cancer Treatment.靶向转录因子治疗癌症。
Molecules. 2018 Jun 19;23(6):1479. doi: 10.3390/molecules23061479.
7
Dynamic contrast-enhanced magnetic resonance imaging for head and neck cancers.动态对比增强磁共振成像在头颈部癌症中的应用。
Sci Data. 2018 Feb 13;5:180008. doi: 10.1038/sdata.2018.8.
8
A Multi-Institutional Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameter Calculations.多机构动态对比增强磁共振成像参数计算比较。
Sci Rep. 2017 Sep 11;7(1):11185. doi: 10.1038/s41598-017-11554-w.
9
HOXB9 Expression Correlates with Histological Grade and Prognosis in LSCC.HOXB9表达与喉鳞状细胞癌的组织学分级及预后相关。
Biomed Res Int. 2017;2017:3680305. doi: 10.1155/2017/3680305. Epub 2017 Jul 20.
10
Current relevance of hypoxia in head and neck cancer.缺氧在头颈癌中的当前相关性。
Oncotarget. 2016 Aug 2;7(31):50781-50804. doi: 10.18632/oncotarget.9549.
Int J Biochem Cell Biol. 2012 Nov;44(11):1852-61. doi: 10.1016/j.biocel.2012.06.025. Epub 2012 Jun 26.
4
Promoter methylation in head and neck tumorigenesis.头颈部肿瘤发生过程中的启动子甲基化
Methods Mol Biol. 2012;863:187-206. doi: 10.1007/978-1-61779-612-8_11.
5
PI3K signalling: the path to discovery and understanding.PI3K 信号通路:探索与理解之路。
Nat Rev Mol Cell Biol. 2012 Feb 23;13(3):195-203. doi: 10.1038/nrm3290.
6
Molecular changes in the multistage pathogenesis of head and neck cancer.头颈部癌症多阶段发病机制中的分子变化。
Cancer Biomark. 2010;9(1-6):325-39. doi: 10.3233/CBM-2011-0163.
7
Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1.头颈部鳞状细胞癌外显子组测序揭示 NOTCH1 中的失活突变。
Science. 2011 Aug 26;333(6046):1154-7. doi: 10.1126/science.1206923. Epub 2011 Jul 28.
8
The mutational landscape of head and neck squamous cell carcinoma.头颈部鳞状细胞癌的突变全景。
Science. 2011 Aug 26;333(6046):1157-60. doi: 10.1126/science.1208130. Epub 2011 Jul 28.
9
Hallmarks of cancer: the next generation.癌症的特征:下一代。
Cell. 2011 Mar 4;144(5):646-74. doi: 10.1016/j.cell.2011.02.013.
10
Carbonic anhydrase-9 expression in head and neck cancer: a meta-analysis.头颈部癌症中碳酸酐酶-9 的表达:一项荟萃分析。
Eur Arch Otorhinolaryngol. 2011 May;268(5):661-70. doi: 10.1007/s00405-011-1488-z. Epub 2011 Jan 19.